Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEMA Buprenorphine NX for Induction in Opioid Dependence
NCT01713803Phase 3Withdrawn
- Sponsor
- BioDelivery Sciences International
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by BioDelivery Sciences International. Status: withdrawn.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01713803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01713803.